Harlem AIDS Treatment Group / Harlem Hosp Ctr — New York, New York

Harlem AIDS Treatment Group / Harlem Hosp Ctr is a clinical research site located in New York, New York, United States 10037.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Harlem AIDS Treatment Group / Harlem Hosp Ctr has participated in 26 clinical trials.

Therapeutic areas: Toxoplasmosis, Cerebral, HIV Infections, Meningitis, Cryptococcal.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Pfizer, Glaxo Wellcome.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harlem AIDS Treatment Group / Harlem Hosp Ctr?

Harlem AIDS Treatment Group / Harlem Hosp Ctr has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harlem AIDS Treatment Group / Harlem Hosp Ctr conducted?

Harlem AIDS Treatment Group / Harlem Hosp Ctr has 26 clinical trials on record. Their work covers Toxoplasmosis, Cerebral, HIV Infections, Meningitis, Cryptococcal.

Is Harlem AIDS Treatment Group / Harlem Hosp Ctr accredited by Crixeo Health?

Harlem AIDS Treatment Group / Harlem Hosp Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harlem AIDS Treatment Group / Harlem Hosp Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.